The acquisition of antigen experience is marked by the generation and the persistence of memory T cells, which can provide life-long protection against pathogens. Studies of mouse models have shown the robust generation of memory T cells that occurs in response to diverse pathogens, and the efficacious protective responses of these cells following reinfection; however, the role of memory T cells in protecting and maintaining long-term health in humans is less clear.
The acquisition of antigen experience is marked by the generation and the persistence of memory T cells, which can provide life-long protection against pathogens. Studies of mouse models have shown the robust generation of memory T cells that occurs in response to diverse pathogens, and the efficacious protective responses of these cells following reinfection; however, the role of memory T cells in protecting and maintaining long-term health in humans is less clear.
In mouse models, it is well-documented that antigenspecific naive CD4 + or CD8 + T cells become activated following antigen exposure, and that populations of these cells subsequently undergo proliferative expansion and differentiation into effector T cells. It is generally thought that these activated, effector T cell populations contain the precursors of antigen-specific long-lived memory T cells, which persist in vivo as heterogeneous populations in multiple sites, and can coordinate protective immune responses following pathogen re-exposu re. Mouse memory CD8 + T cell-mediated protection has been shown in the well-characterized lymphocytic choriomeningitis virus (LCMV) infection model and for additional mouse pathogens (reviewed in REFS 1, 2) . In mice, memory CD4 + T cells can similarly mediat e protective immune responses to influenza virus [3] [4] [5] , Mycobacterium tuberculosis 6 and parasite 7 infections. Although most of our current understanding of memory T cell generation, function and maintenance is based on results from mouse models, studies in mice cannot recapitulate the exposure to multiple pathogens that occurs in humans over decades. The duration of a mouse memory study is typically several months (the lifespan of laboratory mice can be 2-3 years), which constitutes only a small fraction of the duration of immuno logical memory that occurs over many decades in humans (who have an average lifespan of 75 years). In addition, humans are exposed to diverse pathogens through the aerodigestive tract, genital mucosa and skin, which are sites of extensive colonization by >2,000 species of commensal microorganisms 8 . By contrast, most experimental mice are maintained in highly stringent, pathogen-free conditions that limits the breadth of their commensal diversity. Therefore, the generation and the maintenance of human memory T cells should be considered in the context of the unique human exposure to pathogenic and non-pathogenic microorganisms, and not only relative to mouse models in controlled in vivo settings.
Human T cell studies are generally limited in two respects: first, most studies sample only peripheral blood, although the vast majority of memory T cells reside in tissue sites, including lymphoid tissues, intestines, lungs and skin (see below); and second, most studies on human memory T cells use samples that are obtained from young or middle-aged adults, although the majority of memory T cell responses are formed during childhood from primary infections. However, recent conceptual and technological breakthroughs now enable novel investigations of T cell responses in humans. In this Review, we integrate these new studies with previous findings from T cells isolated from healthy and diseased patients to assess our current knowledge Nature Reviews | Immunology 
Memory homeostasis
The stable maintenance of memory T cell numbers through multiple mechanisms, including continuous turnover, responses to homeostatic cytokines and non-cognate T cell receptor interactions.
Immunosenescence
The decreased function of the immune system with age. In particular, the number of naive T cells decreases as thymic function decreases.
of human memory T cells. We describe recent studies that are beginning to investigate how memory T cells are organized in human tissue sites, including their functional capacities and antigen specificities, and we discuss the implications of these insights for promoting in situ immunity in response to vaccines that use targeted therapies. We also discuss the accumulation of memory T cells over a lifetime and how compartmentalization and specificity of memory T cells is maintained through homeostasis.
Memory T cell accumulation throughout life
The frequency of memory T cells undergoes dynamic changes throughout an individual's lifetime that can be divided into three phases: memory generation, memory homeostasis and immunosenescence (FIG. 1) . At birth, all T cells in the peripheral blood are naive, and memory T cells develop over time in response to exposure to diverse antigens. A marked increase in the proportion of circulating memory T cells occurs in the first decade of life, and memory T cells constitute up to 35% of circulating T cells by the end of the second decade of life 9 . During this initial memory generation phase, particularly during infancy and early childhood, individuals have the highest susceptibility to pathogens, as measured by infectious disease hospitalization rates 10 . The second phase, termed memory homeostasis, begins in the third decade of life, when circulating memory T cell frequencies reach a plateau and remain stable throughout adulthood 11,12 (FIG. 1) . Thymic output gradually decreases during this phase and T cell numbers are mostly maintained through homeostatic cell turnover 13 . Individuals in these middle years of life are less susceptible to pathogens, as shown by the low hospitalization rate of infectious diseases 10 , and the immune response is directed to homeostasis. After decades of stable memory T cell frequencies, the proportion and the functionality of memory T cells becomes altered during immuno senescence, starting at 65-70 years of age 9,12,14 . Immunosenescence also marks an increased susceptibility to pathogens that is partly caused by age-associated immune dysregulation and nonimmune-related physiological decline. As immunosenescence has recently been reviewed elsewhere 14, 15 , we focus below on the first two phases: memory generation and homeostasis.
Memory T cell frequency in the blood is a marked underestimate of the total frequency and numbers of memory T cells in the whole body. Estimates of the number of T cells in human tissues are 2 × 10 10 in the skin 16, 17 , 1 × 10 10 in the lungs 18 , 3 × 10 10 in the intestines 19 and 20 × 10 10 in lymphoid tissues (that is, the spleen, the lymph nodes and the bone marrow) 19 . Therefore, peripheral blood T cells (5-10 × 10 9 in human blood) represent only 2-2.5% of the total T cell complement in the body 19 , and memory T cells represent the predominant T cell subset in mucosal sites, skin, spleen and bone marrow 20 . Early in infancy, T cells are observed to populate the intestines 21 and the lungs 22 , with 20% of these cells in the intestines showing a memory phenotype in newborns 21 , perhaps owing to the antigens that they encountered in utero (see below). Recent studies in human tissues (described below) have shown that, by the end of puberty, lymphoid tissues, mucosal sites and the skin are predominantly populated by memory T cells, which persist throughout adult life and which represent the most abundant lymphocyte population in the body 11, 23 . Memory T cell subsets and heterogeneity Heterogeneity in peripheral blood. Memory T cells in humans are classically distinguished by the expression of the CD45RO isoform and by the lack of expression of the CD45RA isoform (CD45RO + CD45RA -) 24, 25 . CD45RO + CD45RA -T cells are now known to comprise heterogeneous populations of memory T cell subsets. Nearly 15 years ago, Sallusto, Lanzavecchia and colleagues 26 first identified this heterogeneity in human peripheral blood on the basis of the expression of the lymph node-homing CC-chemokine receptor 7 (CCR7). Naive T cells uniformly express CCR7, which reflects their predominant residence in lymphoid tissue, whereas memory T cells are subdivided into CD45RA -
CCR7
+ central memory T (T CM ) cells, which traffic to lymphoid tissues, and CD45RA -CCR7 -effector memory T (T EM ) cells, which can migrate to multiple peripheral tissue sites. The authors also showed that T CM cells produced more interleukin-2 (IL-2) than T EM cells, which in turn produced more effector cytokines, and they proposed a differentiation model in which T CM cells . Their levels subsequently plateau and are maintained through homeostasis throughout adulthood (ages 30-65 years), after which time they enter the third stage and show senescent changes (age >65 years). Previous studies have shown that there is an increase in the frequency of memory T cells in the blood (red line) over time 9, 12 . In the whole body, which includes the blood, intestines, lungs, skin, liver, brain and lymphoid tissues, the overall frequency of memory T cells (black line) also increases with age
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. The increase in memory T cell frequency throughout the body inversely correlates with a decreased susceptibility to pathogen infection (dashed line), as calculated from infectious disease hospitalization rates ( 27 . The existence of T CM and T EM cell subsets in lymphoid and peripheral tissue sites was confirmed in mouse models 28, 29 . The original model of functional memory T cell subsets has since been revised to include a further characterization of human peripheral blood memory T cell subsets in health and disease. An effector functional capacity is not confined to T EM cells, as both T CM and T EM cell subsets produce effector cytokines in response to viruses, antigens and other stimuli [30] [31] [32] [33] , although T CM cells show a higher proliferative capacity 30, 34 . The expression of additional surface markers, including the death receptor CD95 (also known as FAS) and the memory-associated marker CD122 (also known as IL-2Rβ), in the context of naive-appearing T cells was recently found to delineate a new memory T cell subset in humans 35 and mice 36 , designated stem cell memory T (T SCM ) cells, which have superior survival potential and efficiently engraft in allogeneic transplant models. In humans, T SCM cells resemble naive T cells in that they are CD45RA + CD45RO -and they express high levels of the co-stimulatory receptors CD27 and CD28, IL-7 receptor α-chain (IL-7Rα), CD62L and CCR7. T SCM cells have a high proliferative capacity and are both selfrenewing and 'multipotent' , in that they can further differentiate into other T cell subsets, including T CM and T EM cells 35, 37 . These properties define their 'stem cell-like' capacities 35, 38 . Elucidating the differentiation pathways for heterogeneous memory T cell subset development following naive T cell activation has been an area of active debate and investigation. Although the lineage relationship of human T cell subsets is difficult to determine, a progressive differentiation pathway based on signal strength and/or extent of activation, places naive, T SCM , T CM and T EM cells in a differentiation hierarchy, in which these cells function as precursors for effector T cells [38] [39] [40] (FIG. 2) . Another model suggests that the T EM and T CM cell subsets derive from effector T cells, with T EM cells giving rise to T CM cells. A third model posits a divergent generation of effector, T CM and T EM cell subsets (reviewed in REF. 41 ). Recent studies of the fate of individual T cells in mice during infection provides evidence that a single naive T cell can give rise to heterogeneous memory T cell populations following activation [42] [43] [44] and supports a progressive differentiation model (FIG. 2) . Moreover, these individual fates in mouse T cells can be determined at early times after activation as a result of asymmetrical cell division 45 . The mechanisms and the timing of human effector and memory T cell fate determination remain undefined.
The heterogeneity of memory T cell subsets in peripheral blood shows only a small fraction of the total complexity of memory T cell distribution throughout the body. Seminal mouse studies showed that antigenspecific memory CD4 + and CD8 + T cells can populate and persist in multiple tissue sites long after virus or antigen was cleared 28, 29 . Early studies of surgical explants in humans showed that CCR7 -T EM cells were the predominant memory T cell subset found in the intestines and the lungs, whereas tonsils contained both T CM and T EM cells 46 . This diverse tissue distribution of memory T cells raised the question of whether they had just circulated through these tissues or whether they had become resident at these sites as a consequence of further differentiation.
In the past several years, mouse studies have established the existence of a new tissue-resident memory T (T RM ) cell subset as a non-circulating subset that resides in peripheral tissue sites and, in some cases, elicits rapid in situ protective responses. Mouse CD4 + T RM cells can be generated in the lungs from adoptive transfer of activated (effector) T cells 4 or following respiratory virus infection 47 , and are distinguished from splenic and circulating memory T cells by their upregulation of the early activation marker CD69, their tissue-specific retention in niches in the lungs 47 and their enhanced ability to mediate protection against influenza virus infection compared to circulating memory CD4 + T cells 4 . An analogous non-circulating CD4 + T RM cell subset has been identified in the bone marrow of mice following systemic virus infection and these cells show enhanced helper functions 48 .
Memory CD8
+ T cells were initially found to persist as circulating and resident populations in lymphoid tissues, lungs and mucosal tissues in mice 49 . CD8 + T RM cells generated following infection have subsequently been identified in multiple mouse tissues, including the skin 50, 51 , vaginal mucosa 52, 53 , intestines 49, 54, 55 , lungs 47, 56 and even the brain 57 . CD8 + T RM cells are collectively distinguished from splenic and circulating memory CD8
+ T cells by their increased expression of CD69 (similarly to CD4 + T RM cells) and by their expression of the epithelial cell-binding αEβ7 integrin (also known as CD103) 20, 52, [58] [59] [60] . Protection by CD8 + T RM cells has been shown to occur in the skin of mice in response to intradermal herpes simplex virus 2 (HSV2) infection [61] [62] [63] and to HSV1 and HSV2 infections at the vaginal mucosa 52, 53 . These mouse studies indicate that T cell-mediated memory responses, and in particular those with high protective capacity, are highly compartmentalized in tissue sites, which necessitates the study of memory T cell populations in anatomical sites other than the blood.
Although T RM cells are less well characterized in humans than in mice, recent studies have started to define these populations by sampling tissues from organ donors 11 and from surgical explants 18, 50 . A whole-body analysis of T cells in multiple lymphoid and mucosal sites revealed that memory CD4 + T cells predominate throughout the body and persist as CCR7 + or CCR7 -subsets that are localized to lymphoid tissues and mucosal sites, respectively. Conversely, memory CD8
+ T cells were shown to persist mainly as CCR7 -subsets in all sites, with low numbers of CD8 + T CM cells in lymphoid tissues and negligible numbers of these cells in other sites 11 . Importantly, most memory T cells in human mucosal, lymphoid and peripheral tissue sites such as the skin express the putative T RM cell marker CD69 20, 58) , whereas circulating blood memory T cells uniformly lack CD69 expression 11 . Taken together, these studies suggest that CD69 + T RM cells are present as major populations in human mucosal and peripheral tissue sites, similarly to their counterparts in mice. In contrast to mouse lymphoid memory T cells, a large proportion of T EM cells in human lymph nodes and spleen also express CD69 (REF. 11), which suggests that T RM cells may also be present in lymphoid tissues.
The pathways and the mechanisms that are responsible for the generation of T RM cells remain unknown and are important areas for future studies. Mouse studies suggest that T RM cell generation occurs within tissue sites from either activated effector T cells and/or T EM cell precursors that migrate to tissue sites 47, 64 (FIG. 2) .
We propose that the pathway to human T RM cell development involves both migration and tissue-specific factors, as suggested by the examination of T RM cell distribution and properties 11, 16, 18 (FIG. 3) . Bloodborne memory T CM and T EM cell subsets can enter certain tissue sites such as the spleen, lungs, lymph nodes and bone marrow at a low frequency, but are not markedly represented in the skin and intestines (T SCM cells are present in the lymph nodes in non-human primates 65 but their distribution in humans is not known Human T RM cells also have tissue-specific properties (FIG. 3) , which suggests that they have in situ influences. T RM cells in the skin express cutaneous lymphocyte antigen (CLA; a glycoform of PSGL1) and the skin-homing chemokine receptors CCR4 and CCR10 (REFS 16, 67, 68) ; memory T cells in the small intestines and colon express the gut-homing receptor CCR9 (REF. 69 ) and α4β7 integrin 70 ; and memory T cells in the lungs upregulate CCR6 expression 18 . There is also evidence for crosstalk between mucosal sites such as the lungs and the intestines 71 . Migration of T EM cells to the bone marrow in mice requires expression of α2β1 integrin (also known as VLA2) 64 , but it is not known whether human bone marrow T RM cells have a similar requirement. This differential chemokine receptor and/or integrin expression may derive from activated or effector populations that enter the site 72, 73 , or alternatively these proteins might be upregulated during the homeostasis of naive or memory T cells 74 . This identification of human T RM cells with tissue-specific signatures suggests that there is anatomical control of memory T cell generation in humans.
Functional capacity of heterogeneous subsets. The extensive phenotypic and tissue complexity among heterogeneous memory T cell subsets suggests that there is a corresponding functional heterogeneity. Mouse and human CD4 + T cells of a non-regulatory lineage are subdivided into functional subsets -the most prevalent being T helper 1 (T H 1) cells that produce interferon-γ (IFNγ), IL-2 and tumour necrosis factor (TNF), T H 2 cells that secrete IL-4, IL-5, IL-10 and IL-13, and T H 17 cells that produce IL-17. CD8 + T cells are not typically subdivided into functional subsets and generally produce IFNγ and TNF, and express cytolytic markers such as perforin and CD107. In the peripheral blood of healthy individuals, most circulating memory CD4 + and CD8 + T cells produce IFNγ, IL-2 and/or TNF following short-term stimulation, and only low numbers of IL-4-producing, IL-10-producing and IL-17-producing memory CD4 + T cells are observed 35, 75 . Human peripheral blood T EM , T CM and T SCM cell populations differ in the relative proportion of cells that produce IL-2, IFNγ and/or TNF: T EM cells have the highest proportion of IFNγ-producing and TNF-producing cells and the lowest proportion of IL-2-producing cells; T SCM cells have the lowest proportion of IFNγ-producing cells and more IL-2-producing cells compared with T EM cells; and the T CM cell population has the highest frequency of IL-2-producing cells with proportions of IFNγ-producing and TNF-producing cells that are intermediate between the T SCM and T EM cells 35, 38 (FIG. 3) . Variations in the expression of chemokine receptors have also been associated with different functional capacities of human effector T cells; for example, in vitro polarized T H 1 cells were found to express CXC-chemokine receptor 3 (CXCR3), CCR2 and CCR5, whereas T H 2-polarized cells expressed CCR3 and CCR4 (REF. 76 ). However, the expression of these chemokine receptors can be transient depending on the microenvironment 77 and does not consistently delineate functional subsets among resting memory T cells They also migrate via the lymphatics and efferent vessels to the lymph nodes. T RM cells predominate in the skin, the lungs, the bone marrow and the intestines, but may also be present within the CD69 + T EM cell subsets in the spleen and the lymph nodes (not shown). The expression of certain chemokine receptors and/or integrins is associated with T cell migration and/or residence in the lymph nodes (CC-chemokine receptor 7 (CCR7)), the skin (CCR4, CCR10 and cutaneous lymphocyte antigen (CLA)), the intestines (CCR9 and α4β7 integrin), the lungs (CCR6) and the bone marrow (α2β1 integrin). b | Key phenotypic and functional properties of circulating and resident subsets are shown; CD45RA and CCR7 distinguish circulating memory T cell subsets, and CD69 (and CD103) expression delineate T RM cells. Memory T cell subsets can produce similar types of recall cytokines, such as interleukin-2 (IL-2), interferon-γ (IFNγ) and tumour necrosis factor (TNF), but they differ in the extent and the quality of these responses. +, low expression levels; ++, medium expression levels; +++, high expression levels. Dashed lines indicate putative migration patterns from mouse studies. 
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The functional capacities of human T RM cells are beginning to be defined. Overall, memory CD4 + and CD8 + T cells in lymphoid and mucosal tissues obtained from healthy individuals show rapid IL-2 and IFNγ production, respectively, when nonspecifically activated with the mitogens phorbol 12-myristate 13-acetate (PMA) and ionomycin 11 . It was previously determined that individual circulating memory T cells can produce multiple cytokines, and the presence of these multifunctional or polyfunctional memory T cells correlated with superior recall and protective memory responses 79 . There is emerging evidence that T RM cells can be multifunctional and that they have qualitative functional differences. Human bone marrow T RM cells are polyfunctional for effector cytokines and cytolytic molecules 48, 80 , a substantial proportion of human lung T RM cells produce multiple proinflammatory cytokines 18 , and human intestinal T RM cells are also polyfunctional 11 . However, other functions seem to be confined to specific subsets and/or tissue sites. IL-17 is produced by a subset of CD4 + T RM cells in mucosal sites, particularly in intestines of healthy individuals 11 , by CCR6 + memory T cells in peripheral blood 81, 82 and also by a subset of CD161 + T cells in inflamed tissue, such as the skin of patients with psoriasis 83 . A subset of skin memory CD4 + T cells can produce IL-22 (but not IL-17) when cloned and expanded ex vivo 84 , and IL-22-producing T cells have also been identified in inflamed skin in patients with psoriasis 85 . Thus, although predominant memory T cell functions, such as IFNγ production, are broadly distributed among multiple memory T cell subsets and tissues, T RM cells in tissue sites can adopt multiple or distinct functional attributes that may also depend on tissue-specific inflammation.
Antigen specificity and diversity Specificity in the adaptive immune response is intricately linked to the establishment and persistence of memory T cells that record previous antigen experiences via specific T cell receptors (TCRs). In mice, the development of memory T cells in response to viral pathogens is marked by extensive clonal expansion of virus-specific T cells, followed by the contraction and death of >90% of activated or effector T cells, as well as the long-term persistence of virus-specific memory T cells at variable frequencies (<1 to >10% of the total number of T cells) depending on the virus 2, 86 . These mouse models are generally used to investigate memory T cell development and responses to one type of virus in otherwise sterile conditions. By contrast, in humans, antigenspecific memory T cells are generated and dynamically maintained as a heterogeneous T cell population in the context of thousands of different pathogens that are introduced at various stages of life. Therefore, assessing the physiological importance of antigen-specific memory T cells in humans has proved challenging.
Pathogen-specific memory generation and maintenance.
Our ability to measure the frequency of human antigenspecific memory T cells has increased in accuracy and sensitivity from classical functional recall assays to cytometry-based methods
. The assessment of human antigen-specific memory T cells has mostly occurred in the context of virus infections that are ubiquitous in healthy humans, including acute infections with influenza virus and chronic infections with viruses such as cytomegalovirus (CMV) and Epstein-Barr virus (EBV). Memory T cell responses to these viruses are generated as a result of a productive immune response that effectively controls the virus. Human T cell responses in chronic HIV infection have been extensively studied; however, mechanisms for their generation and maintenance are more complex, as memory T cells are the targets for chronic infection and virus persistence [87] [88] [89] , and HIV is not cleared by the immune system in most individuals (reviewed in .
Cross-sectional studies of memory T cell frequency in different age groups show that most virus-specific memory T cells are generated early in life. Congenital CMV infection was shown to result in the generation of virus-specific memory CD8 + T cells in utero 93 . Furthermore, in a large cohort study of children and adults, CMV-specific CD8 + T cells were detected in the blood of infants and their frequency remained stable throughout early childhood and young adulthood 94 . Memory T cells that are specific for adenovirus are detected in early childhood and progressively increase in frequency until the age of 10 years, from which time they remain at a constant level throughout adulthood 31 . In addition, influenza virus-specific T cells are detected in children at levels that are comparable
Box 1 | Approaches to analyse antigen-specific T cell memory
The techniques for examining antigen-specific T cell responses have increased in sensitivity and specificity in recent years. The classical limiting dilution assay requires ex vivo antigen-driven expansion of human T cell populations, but this approach is imperfect because non-proliferating T cell clones are under-represented. The development of the ELISPOT (enzyme-linked immunosorbent spot) assay has more recently provided a sensitive but robust functional method to detect antigen-specific memory T cells using their rapid production of effector cytokines, and has enabled their precise quantification without the need for antigen-driven population expansion.
The development of MHC tetramer reagents 148 facilitated the visualization and the quantification of epitope-specific T cells solely on the basis of T cell receptor (TCR) specificity, although this approach lacks a functional readout. TCR staining with tetramers, pentamers or MHC multimers has facilitated a more sensitive estimation of memory T cell specificity in humans compared with direct functional recall responses to antigens as measured by ELISPOT or limiting dilution assays 149, 150 . Moreover, new techniques to enrich antigen-specific T cells using labelled tetramer reagents and secondary binding reagents coated to magnetic beads 115 have facilitated the detection of rare antigen-specific T cell populations, even among naive T cell populations that have not undergone in vivo expansion.
The most recent technical advance in antigen-specific T cell detection is achieved through the use of cytometry by time-of-flight mass spectrometry (CyTOF), which applies the technique of mass cytometry by using antibodies labelled by lanthanides with different atomic masses, facilitating >50 parameters to be investigated on single cells 151 without the problems of compensation that occur in multiparameter flow cytometry. Coupling different mass labels to tetramer reagents facilitates the combinatorial assessment of >50 TCR specificities in a single sample 152 . The use of these new technologies makes the assessment of T cell epitope specificities from small clinical biopsy samples possible, which will be essential for the future diagnostic application of TCR antigen specificities in immune monitoring.
to those observed in adults 95, 96 . Taken together, these results suggest that, despite the overall increase in circulating memory T cells over a lifetime (FIG. 1) , memory T cells that are generated against ubiquitous pathogens increase in frequency in early life and are stably maintained throughout adulthood.
The ability to observe pathogen-specific human memory T cell development throughout the processes of clonal expansion and contraction is not readily accomplished; however, prospective infection and vaccine studies have provided novel glimpses into this process. Circulating T cells that are specific for EBV or for influenza virus underwent clonal expansion, contraction and persisted as memory T cells following acute infection [97] [98] [99] . Similarly, the administration of yellow fever and smallpox vaccines, which both consist of live viruses, stimulated robust CD8 + T cell clonal expansion, contraction and memory formation that is measurable in the peripheral blood 100 . However, there was no discernible increase in the frequency of circulating virus-specific T cells following acute infection with rotavirus 101 , which is a gastrointestinal virus, or with the lung pathogen respiratory syncytial virus (RSV) 102, 103 . This variability in observing memory T cell development in human blood may be due to inefficient mobilization of memory responses during infection 104 and/or compartmentalization of pathogen-specific responses at the infected site.
Several studies have shown that there is a higher generation and maintenance of virus-specific effector and memory T cells in tissues compared with the circulation. Intradermal immunization with purified protein derivative (PPD) of M. tuberculosis resulted in the proliferation of antigen-specific T cells in the skin but not in the blood 105 . Similarly, cutaneous challenge with varicella zoster virus resulted in memory T cell accumulation in the skin 106 , which suggests that the formation of memory T cells may occur at distinct sites. Lung tissue was found to contain an increased frequency of influenza virus-specific memory CD8 + T cells compared to the blood 107, 108 and the spleen 47 , and influenza virus-specific T cells in human lungs were found to have a T RM cell phenotype (that is, CD69 + CD103 + ) 47, 109 . CD8 + T cells that are specific for HSV2 were found to persist in genital skin, but not in skin from other body regions 110 , which suggests that skin T RM cells are locally maintained. Similarly, memory CD4 + T cells that are specific for astrovirus, which is a common enteropathogenic virus, were detected in the small intestines 111 . Taken together, these results suggest that compartmentalization of pathogen-specific memory T cell responses are preferentially maintained at the sites of initial effector T cell recruitment. These findings also indicate that accurate assessment of pathogen-specific memory T cell responses probably requires sampling of the initial infection site.
Memory T cell cross-reactivity.
Despite their specificity, human memory T cells cross-react with antigenic epitopes that have not previously been encountered, which is possibly due to intrinsic properties of TCR recognition 112 and to the range and the breadth of human antigenic experience. Memory CD4 + and CD8 + T cells that were specific for unique epitopes of avian influenza strain H5N1 were detected in healthy individuals that were not exposed to H5N1 infection, as assessed by serology 113, 114 . In addition, HIV-specific memory T cells have been identified in HIV-negative individuals 115 . Virus-specific memory T cells also cross-react with alloantigens, autoantigens and unrelated pathogens 116, 117 : EBV-specific human memory T cells generated in HLA-B8 individuals showed allogeneic cross-reactivity to HLA-B44 (REF. 118 ), and influenza virus-specific and HIV-specific memory CD4 + T cells recognized epitopes from unrelated microbial pathogens 115 . Furthermore, T cells that were specific for the autoantigen myelin basic protein (MBP) recognized multiple epitopes from viral and bacterial pathogens 117, 119 . This cross-reactivity may enable memory T cells to mediate protection without an initial disease -a phenomenon known as heterologous immunity 120 . Heterologous immunity has been shown to occur in humans; cross-reactive influenza virus-specific T cells were shown to be activated and to proliferate by EBV infection 121 .The role of T cell cross-reactivity in determining how T cell subsets may be compartmentalized in tissue sites is not known, but could be an important mechanism for their homeostatic maintenance (see below).
Role of microbiome in generating memory T cells.
Mucosal sites and the skin harbour resident bacteria and viruses, which are collectively referred to as the microbiome. Humans are exposed to >2,000 microbial species 8 , of which only a small proportion are pathogenic. It has been suggested that the very purpose of immune memory in vertebrates is to preserve proper immune homeostasis with commensal microorganisms 8 . Studies in mouse models show that the presence and the composition of the microbiome are crucial in promoting appropriate immune responses to pathogens and in maintaining proper immune homeostasis (reviewed in REF. 122 ). Whether the species of commensal microorganisms that are present in certain sites influence the type of memory T cells that reside there is not known. In a limited study investigating the reactivity of T cells expanded from the blood and from intestinal biopsy samples of two patients to endogenous bacterial flora, more bacteria-reactive T cells clones were isolated from the intestines than from the blood 123 , which suggests that intestinal T cells may have biased cross-reactivity to intestinal flora. Although memory T cells that are specific for commensal bacteria have recently been detected in mice 124 , they are associated with pathogenic infection of the intestines and could be a consequence of dysregulated immunity in inflammatory bowel disease. By contrast, in humans, memory T cells survive far longer and are exposed to more antigens during their lifetime, and therefore commensal microorganism-specific responses may be part of the healthy immune balance between the microflora and the indigenous T cells. Human memory T cell homeostasis Specific clones of memory T cells that express a unique TCR can persist for decades in vivo. Human memory T cell longevity is clearly shown by studies indicating that memory T cells specific for vaccinia virus -the aetiological agent of smallpox, which was eradicated four decades ago -persisted in individuals who had been vaccinated 25-70 years previously 125 . However, the mechanisms for memory T cell maintenance in humans remain unclear. In mouse models, the longterm requirements for T cell maintenance and homeostasis have been defined using mice that are deficient for various cytokines and cytokine receptors, for MHC molecules and/or for components of the TCR signalling cascade (reviewed in REF. 126 ). These studies established that virus-specific memory CD8 + T cells do not require antigens or MHC molecules for their maintenance, but rather that they rely on IL-15 for homeostasis and IL-7 for survival. By contrast, these studies showed that memory CD4 + T cells require TCR signalling and/or MHC class II molecules for their functional maintenance and homeostasis [127] [128] [129] . An elegant approach to probe human memory T cell turnover or longevity is to administer deuterated water or deuterated glucose to volunteers and, subsequently, to examine the incorporation of deuterium by T cells in vivo 130, 131 . The calculated half-life of human T cells using this approach was found to vary according to the type of labelling, the limited sampling of peripheral blood, the timing of sampling and the mathematical algorithm 132 . On average, human naive T cells have a longer half-life than memory T cells (1- 134 , which indicates that they have a more extensive replicative history. These studies suggest that memory T cells in the circulation are partly maintained by continuous homeostatic turnover. Turnover and replicative history of human memory T cells in tissue compartments remains completely uninvestigated and will be important to assess T RM cell stability.
Transcriptome, epigenetic and deep-sequencing analysis of human memory T cells provide new evidence about the mechanisms that are responsible for memory T cell longevity 135, 136 and the potential role of TCR and cytokine signals in this process. Human memory CD4
+ and CD8 + T cells show transcriptional upregulation of genes that encode TCR-coupled activation markers compared with naive T cells, including multiple MHC class II molecules, chemokine receptors, CD95 and effector molecules 135 . Moreover, activation-induced epigenetic changes in the loci of effector cytokine genes are maintained in circulating human memory CD8 + T cells 135, 137 . Deep sequencing of TCR genes revealed that there are conserved clonotypes and reduced diversity among human memory T cell subsets 138, 139 . Taken together, these findings implicate tonic TCR signalling in human memory CD4 + and CD8 + T cell maintenance, potentially as a result of crossreactivity with self antigens, environmental antigens and/or resident commensal organisms. Requirements for cytokine signals in this maintenance are not clearly defined, although individuals who have mutations in the cytokine-induced transcription factor signal transducer and activation of transcription 3 (STAT3) have reduced memory T cell frequency and responses 140 . Whether requirements for T RM cell maintenance differ according to the tissue site is not known; for example, memory T cells may be preferentially maintained by cross-reactive TCR-mediated interactions with microbial antigens at mucosal sites as a result of the high antigen density, whereas those in the blood, lymphoid The relative naive and memory T cell subset frequencies are shown in the circulation and the peripheral sites, as well as at different stages of life (infant, 0-2 years of age; youth, 2-14 years of age; young adult, 15-25 years of age; adult, >25 years of age). The schematic also shows the biased specificity for certain pathogen-derived antigens that has been observed in specific tissue sites, including antigens derived from cytomegalovirus (CMV) in the blood, Epstein-Barr virus (EBV) in the spleen, vaccinia virus in the lymph nodes, influenza virus in the lungs, rotavirus in the intestines, and herpes simplex virus (HSV) and varicella zoster virus (VZV) in the skin. In addition, the specificities of some memory T cells at mucosal sites (for example, the lungs, intestines and skin) are biased for antigens from the microbiota. At birth, there is a preponderance of naive T cells in the circulation, and an abundance of mucosal microbial antigens are encountered during infancy, which results in seeding of mucosal sites with effector memory T (T EM ) cells that are specific for mucosal pathogens; these cells could develop into tissue-resident memory T (T RM ) cells in situ. Although cell numbers in human skin have not been quantified in individuals of different ages, infant skin is likely to contain few T cells based on estimates from older children. During childhood, exposure to the ubiquitous pathogenic and non-pathogenic microbial species occurs in each site and new memory T cells are formed, which are partitioned as T RM cells in the skin and mucosal sites, and as central memory T (T CM ) cells in the lymphoid tissues. This partitioning of antigen-specific memory T cell subsets in tissues is maintained during adulthood, with more T EM and T CM cell subsets gradually accumulating in the circulation and the lymph nodes, which could potentially replenish and/or convert to T RM cells that are lost through attrition. Data showing the relative frequencies of each T cell subset in each tissue site for youths to adults are compiled from REF. 11 , and are extrapolated for infants on the basis of REFS 21, 22. tissue, spleen and bone marrow may be preferentially maintained through responses to homeostatic cytokines such as IL-7 or IL-15, which are expressed at these sites 64 .
Antigen-specific memory T cells in space and time.
Suggestions have been made about how T cell subsets and their specificities for ubiquitous microbial antigens are distributed in space (from the circulation to the peripheral tissue sites) and time (from infancy to old age) (FIG. 4) . T EM and T RM cell compartmentalization in mucosal and peripheral tissue sites is initiated during infancy and is stably maintained throughout life. T RM cell populations in these sites may be enriched for cells specific for pathogenic and non-pathogenic microbial species that populate or that infect these tissues. Dynamic changes occur in the circulation and in the lymphoid tissue, including the reduction in naive T cells and the increase in T CM and T EM cell subsets that occurs with increasing age. Circulating T EM cell populations may be enriched for cells that are specific for chronic and systemic pathogens, but not for those that are specific for microbiota in tissues. We hypothesize that this sequestration of memory T cell specificities in distinct anatomical compartments could be a mechanism to stabilize and to preserve pathogen-specific memory T cells, and to maintain immune homeostasis in the body. Through additional tissue sampling and integration of large data sets using computation and statistical approaches, it will be possible in future studies to directly test this model (FIG. 4) and to map the organization of T cell subsets and their specificities within the human body throughout life.
Implications for vaccines
The induction of memory T cells through vaccination has great potential to provide efficacious protective immunity to multiple types of pathogens, including viral, intracellular bacterial and parasitic infections, because of their broad specificity for internal and conserved pathogen epitopes, their residence in diverse sites of infection and their longevity. Immune protection in the context of the vaccines that are currently used is mostly associated with the generation of neutralizing antibodies, and the potential of memory T cells to mediate protection has not been realized 141 . Several recent human challenge studies have shown a correlation between protection and the presence of memory T cells. One such study using influenza virus found a direct correlation between the presence of virus-specific memory CD4 + T cells and reduced illness to influenza virus challenge 142 . In addition, the generation of circumsporozoite protein (CSP)-specific memory CD4 + T cells using a malaria vaccine correlated with protective antiparasite immunity 143 . Multifunctional circulating memory CD4 + T cells are similarly associated with HIV-infected non-progressors 79 . Therefore, although the generation of memory CD8 + T cells is often the focus of mouse studies of immune protection, memory CD4 + T cells may also be a relevant subset to target in humans.
The consideration of the anatomical location of vaccine administration seems to be crucial in the design of vaccines to promote the generation of pathogen-specific memory T cells in the right place and at the right time. Administering a vaccine or an attenuated pathogen at the site of infection in the skin, the lungs, or the rectal or genital mucosal surfaces could enhance the generation of T RM cells in vivo. Studies in mice have tested a 'prime and pull' strategy, in which pathogen-specific T cells are primed using systemic vaccines and are then specifically recruited to a tissue site through the local administration of chemoattractants 53 . In humans, the introduction of the smallpox vaccine through skin scarification promotes local T cell responses and the long-term persistence of vaccinia virus-specific memory CD4 + T cells 23, 125 . There are also promising results from HIV vaccine studies in non-human primate models using CMV-mediated vectors to promote the polyclonal generation of T EM cells to multiple epitopes 144 . HIV subunit vaccination using these CMV vectors administered through multiple routes leads to T EM cell generation and population in mucosal and lymphoid sites, and to the development of lasting protective immunity 145, 146 . These studies show that adjusting the route and the mode of immunization can facilitate memory T cell-mediated protective immunity to intractable pathogens.
Timing is another important consideration for memory T cell generation and for vaccine design. Memory T cells that are generated early in life are maintained at a measurable frequency throughout a healthy adulthood, as shown in studies of the peripheral blood 31, 94 , which suggests that inducing memory T cell generation at an early stage of life, when fewer memory T cells clones are present, enables these cells to establish a niche for long-term persistence. Peripheral tissues have low numbers of memory T cells at birth but become populated by memory T cells by early childhood (see above), which indicates that site-specific vaccines could promote effective tissue targeting at early stages of life. Other considerations, such as targeting tissue dendritic cells for the development of protective immunity at specific sites 71 , and the co-administration of immunomodulators to enhance memory T cell generation 147 , could be integrated into the design of vaccines to generate durable in situ T cell immunity.
Conclusions and perspectives
Improved and more sensitive methods to determine the function and the antigen specificity of memory T cells, combined with high-throughput approaches, enable us to define the molecular landscape of human immune cells. When combined with human tissue and blood samples, we have an unprecedented opportunity to obtain a more comprehensive understanding of the immune system in the context of the human lifespan, which is not possible in animal models. Future studies that investigate site-specific immune responses should focus on understanding how memory T cells are generated in early life and on clarifying the role of the microbiome in these processes to identify novel strategies to promote effective immunoregulation and pathogen-specific immunity.
